Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2von Hippel-Lindau Disease 1Neoplasms 1Neoplasm Metastasis 1Hemangioblastoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

belzutifan 4Everolimus 2vatalanib 1spartalizumab 1palbociclib 1lenvatinib 1cabozantinib 1PT2385 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × von Hippel-Lindau Disease × vatalanib × Clear all
NCT00052013 2017-03-06

Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584

Novartis

Phase 2 Completed
11 enrolled

von Hippel-Lindau Disease, Hemangioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡